Disease burden of Barrett's esophagus across the Paris metropolitan area - 18/05/24
, Mathis Collier d, Viet-Thi Tran b, c, Mourad Dellagi d, Nathanael Beeker dHighlights |
• | The prevalence of Barrett's esophagus among adults in France could reach 2 %. |
• | 11 % of patients with Barrett's esophagus harbor dysplasia or esophageal adenocarcinoma. |
• | Gastro-esophageal reflux symptoms are not more frequent in patients with Barrett's esophagus. |
Abstract |
Introduction |
The prevalence of Barrett's esophagus (BE) in France is unknown. However, the management of dysplastic BE in expert centers is recommended and reduces the risk of developing invasive adenocarcinoma. Our aim was to determine the burden of BE patients in the Paris Region.
Methods |
We performed a retrospective study using the data from electronic medical records from the data warehouse of the 39 Greater Paris public hospitals (Entrepôt de données de santé de l’ Assistance Publique- Hôpitaux de Paris) for the year 2018, and used natural language processing to search for occurrences of Barrett's esophagus in endoscopy and pathology reports.
Results |
we observed a 2.2 % prevalence of Barrett's esophagus. Patients with Barrett's esophagus were older, more frequently males, with a hiatal hernia, proton pump inhibitor users, and less frequently infected by H. Pylori. Gastro-esophageal reflux symptoms were not more frequently encountered in Barrett's patients. Eleven percent of patients with Barrett's esophagus had dysplasia or adenocarcinoma.
Discussion |
Over 200 000 patients with Barrett's esophagus are expected in the Paris Region, of which 11 % harbor dysplasia or adenocarcinoma. This data should be taken into account to tailor healthcare offer in France.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Barrett's esophagus, Esophageal adenocarcinoma
Mappa
| Funding: none |
|
| No support in the form of grants, equipment, drugs, for all of the above. |
Vol 48 - N° 6
Articolo 102371- Giugno 2024 Ritorno al numero
Articolo precedente
- Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis
- Sanjay Bandyopadhyay, Pooja Verma, Shambo Samrat Samajdar, Saibal Das
- The impact of secondhand smoke on failure of Helicobacter pylori therapy is not inferior to that of smoking
- Jiajia Wu, Zheng Qian, Dingfu Zhong, Min Lin
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?